mk2027.bsky.social
@mk2027.bsky.social
npr.org NPR @npr.org · 26d
The drug lenacapavir will be distributed to Eswatini and Zambia — the first step toward providing at least 2 million doses to the countries with the highest HIV burden, largely in Africa, by 2028. n.pr/4i6Ujgd
A 'breakthrough' drug to prevent HIV, an 'unprecedented' rollout
The drug lenacapavir will be distributed to Eswatini and Zambia — the first step toward providing at least 2 million doses to the countries with the highest HIV burden, largely in Africa, by 2028.
n.pr
November 19, 2025 at 7:21 PM
The Trump administration will provide a HIV-prevention drug to countries most affected by the disease in a push to end the spread of the virus that causes AIDS, but won't provide it to South Africa, which has the world’s largest HIV-positive population.
Trump HIV prevention plan shuts out South Africa — the nation most affected
Administration officials say South Africa has “significant means” to fund a promising new drug, lenacapavir, on its own. Critics call the move self-defeating.
www.washingtonpost.com
November 19, 2025 at 7:21 PM
Herpes Simplex Virus and Drug Resistance - Comprehensive Update on Resistance Mutations and Implications for Clinical Management: A Narrative Review

Open Access @cmijournal.bsky.social

www.clinicalmicrobiologyandinfection.com/article/S119... #IDSky #TxID
November 5, 2025 at 7:13 PM
From #SAEMPulse: "Acyclovir- and valacyclovir-associated neuropsychiatric events are rare but serious, and adverse effects are often reversible after discontinuing therapy."

Read now: issuu.com/saemonline/d...
November 5, 2025 at 7:12 PM
Gram-negative rods bacteremia (& multi-organ failure...). This is symmetrical peripheral gangrene, also known as a type of purpura fulminans. It is more formally defined as symmetrical distal ischemic
damage in 2 or more sites in the absence of a major
vascular occlusive disease.
November 5, 2025 at 7:05 PM
A potential new treatment option for Staph bacteremia #Pitt_IDFall25
🆕🌟Excellent review article
P2Y12 inhibitors(eg clopidogrel,ticagrelor)in Staphylococcus aureus bacteraemia: current evidence and clinical implications
Coming soon: CLOPI-SNAP+ Clopido-SNAP #idsky #EMIMCC
www.thelancet.com/journals/lan...
November 5, 2025 at 6:57 PM
Daptomycin-loaded cubosomes killed 14 MRSA isolates in vitro, enhancing efficacy vs. daptomycin alone. In mice, they reduced MRSA organ burden, showcasing a novel delivery method. 🦠💊##idsky
Daptomycin-Loaded Nanocarriers Facilitate Synergistic Killing of Methicillin-Resistant Staphylococcus aureus via Lipid-Mediated Interactions and Targeting
AbstractPreservation and augmentation of existing antimicrobials is crucial in combating antimicrobial resistance. Gram-positive bacteria, exemplified by Staphylococcus aureus, are among the most common human bacterial pathogens, with methicillin-resistant S. aureus (MRSA) now established globally. Daptomycin is a last-line anti-staphylococcal antimicrobial that uniquely targets the bacterial membrane with bactericidal effects. Here, we developed lipid-based nanoparticles, namely cubosomes, to encapsulate daptomycin for targeted delivery via lipid-mediated interactions. Daptomycin-loaded cubosomes synergistically killed 14 clinical MRSA isolates in vitro compared with daptomycin or cubosomes alone. This synergy between daptomycin and cubosome was mediated by cubosomes docking on the S. aureus cell surface, releasing daptomycin for membrane extraction and penetration, followed by lipid cubosome infusion into S. aureus membranes. Using a murine septicemia model, daptomycin-loaded cubosomes significantly reduced the organ bacterial burden of MRSA. Together, these data showed that multifunctional lipid nanocarriers can potentiate the bactericidal activity of daptomycin using a membrane-targeted trojan-horse-like mechanism.
academic.oup.com
November 5, 2025 at 6:53 PM
Non–β-lactam surgical antimicrobial prophylaxis was associated with a 1.8-fold higher odds of surgical site infection compared with β-lactam SAP across all procedure types. ja.ma/3JBkBue
November 5, 2025 at 6:49 PM
𝘗. 𝘢𝘦𝘳𝘶𝘨𝘪𝘯𝘰𝘴𝘢 is a top WHO priority pathogen and a major cause of ventilator-associated and hospital-acquired pneumonia. Many strains exhibit high-level multi-drug resistance. No licensed vaccine exists. Our approach integrates nanotechnology and innate immune stimulation to overcome these barriers.
November 5, 2025 at 6:45 PM
#WHO report shows rising #antibiotic resistance in common bacteria

@katholt.bsky.social & @josebengoechea.bsky.social explain resistance worryingly high in #Klebsiella & E.coli as 1 in 6 lab-confirmed #bacterial infections in 2023 shown resistant to antibiotics.

www.lshtm.ac.uk/newsevents/n...
November 5, 2025 at 6:42 PM
📊 Infection data are back on the UKRR KRT portal!

Explore updated MRSA & MSSA infection rates (2019–2023) in adult haemodialysis patients, with centre comparisons & trends over time.

🔗 public.tableau.com/a...

#RenalData #KidneyCare #MRSA #MSSA #Dialysis
November 5, 2025 at 6:39 PM
We show how bacteria can adapt to B-lactam stress by increasing the copy number of "wimpy" beta-lactamases to overcome new drugs/B-lactamase inhibitors, without de novo evolution. This threatens the beta-lactam dominated antibiotic pipeline.

Congrats @jakechoby.bsky.social and team!
rdcu.be/euijW
Copy number flexibility facilitates heteroresistance to increasing antibiotic pressure and threatens the beta-lactam pipeline
Nature Communications - Choby et al. show that dynamic increases in the copy number of preexisting β-lactamase genes in heteroresistance enables resistance of continua of cellular...
rdcu.be
November 5, 2025 at 6:38 PM
November 5, 2025 at 6:32 PM
♨️♨️♨️ Hot of the press: Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis | New England Journal of Medicine www.nejm.org/doi/full/10....
November 5, 2025 at 6:31 PM
CRISPR-Cascade test detects bloodstream infections in minutes

The test identified Methicillin-Sensitive Staphylococcus aureus (MSSA), Methicillin-Resistant Staphylococcus aureus (MRSA), Escherichia coli (E. coli), and Hepatitis B Virus within ten minutes.

phys.org/news/2025-03...
CRISPR-Cascade test detects bloodstream infections in minutes without amplification
University of Illinois at Urbana-Champaign researchers have developed a CRISPR-based diagnostic tool capable of detecting bloodstream infections in minutes without the need for nucleic acid amplificat...
phys.org
September 5, 2025 at 1:39 AM